Found 6 results
Filters: Author is Gadegbeku, Crystal A  [Clear All Filters]
2017
Nair V, Robinson-Cohen C, Smith MR, Bellovich KA, Bhat ZYousuf, Bobadilla M, Brosius F, de Boer IH, Essioux L, Formentini I et al..  2017.  Growth Differentiation Factor-15 and Risk of CKD Progression.. J Am Soc Nephrol. 28(7):2233-2240.
Afshinnia F, Zeng L, Byun J, Gadegbeku CA, Magnone MChiara, Whatling C, Valastro B, Kretzler M, Pennathur S.  2017.  Myeloperoxidase Levels and Its Product 3-Chlorotyrosine Predict Chronic Kidney Disease Severity and Associated Coronary Artery Disease.. Am J Nephrol. 46(1):73-81.
2016
Gipson DS, Troost JP, Lafayette RA, Hladunewich MA, Trachtman H, Gadegbeku CA, Sedor JR, Holzman LB, Moxey-Mims MM, Perumal K et al..  2016.  Complete Remission in the Nephrotic Syndrome Study Network.. Clin J Am Soc Nephrol. 11(1):81-9.
2015
Ju W, Nair V, Smith S, Zhu L, Shedden K, Song PXK, Mariani LH, Eichinger FH, Berthier CC, Randolph A et al..  2015.  Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker.. Sci Transl Med. 7(316):316ra193.
2014
Martini S, Nair V, Keller BJ, Eichinger F, Hawkins JJ, Randolph A, Böger CA, Gadegbeku CA, Fox CS, Cohen CD et al..  2014.  Integrative biology identifies shared transcriptional networks in CKD.. J Am Soc Nephrol. 25(11):2559-72.
2013
Gadegbeku CA, Gipson DS, Holzman LB, Ojo AO, Song PXK, Barisoni L, Sampson MG, Kopp JB, Lemley KV, Nelson PJ et al..  2013.  Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach.. Kidney Int. 83(4):749-56.